Thank you for submitting your manuscript for consideration by the EMBO Journal. Please let me first apologise again for the time taken in getting back to you with a decision -this was due to a delay in receiving the final referee's report. However, we do now have the comments of all three reviewers, which are enclosed below. As you will see, all three referees express significant interest in your work and are broadly in favour of publication. However, all three do raise a number of concerns that will need to be addressed before we could consider publication in the EMBO Journal. In particular, I would highlight the comments of both referees 1 and 3 regarding the question as to the mammalian kinase involved in this pathway. In addition, referee 3 questions the conclusiveness of the data as to whether Sqa-Sqh is directly involved in autophagosome formation as opposed to in autophagy induction; further data to elucidate the precise physiological function of myosin here would clearly be very valuable.
In the light of the referees' positive recommendations, I would therefore like to invite you to submit a revised version of the manuscript, addressing all the comments of all three reviewers. I should add that it is EMBO Journal policy to allow only a single round of revision. Acceptance of your manuscript will thus depend on the completeness of your responses included in the next, final version of the manuscript. When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as a standard revision time, and as a matter of policy, we do not consider any competing manuscripts published during this period as negatively impacting on the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal REFEREE REVIEWS Referee #1 (Remarks to the Author):
The paper by Tang et al., reveals an interesting new functional link between the autophagic gene Atg1 and myosin II activation in the Drosophila system through a novel myosin light chain kinase named Sqa. A few experiments were performed in mammalian cell cultures as well. Atg1 phosphorylates Sqa and thus increases its catalytic activity towards myosin regulatory light chain causing actomyosin activation. The trans-phosphorylation between the two kinases occurs within the catalytic domain of Sqa in a specific Thr which was shown before to be a critical functional site in a related mammalian kinase named DAPK3. Inhibition of actomyosin activation by a dominant negative mutant of myosin light chain or by some drug inhibitors reduced autophagy induced either by over expressing Atg1 or by amino acid deprivation. Based on immunostaining data and biochemical fractionantions the authors propose that the contribution of actomyosin activation to autophagy is by controlling the re-distribution of Atg9 from TGN to autophagosome structures , i.e., controlling the recycling of Atg9 which is essential for autophagosome formation.
A few issues should be clarified/addressed before this paper can be published.
1. The ultimate proof that Sqa is the relevant kinase that couples activation of Atg1 to autophagosome formation through myosin light chain phosphorylation, in response to nutrient deprivation, is still missing. It is shown that Sqa -RNAi and Sqh non phosphorylatible mutant can each inhibit autophagy; yet epistatic analysis showing that in the physiological context of amino acid starvation they function along the same pathway is missing. It is important to show in a coherent way that MRLC phosphorylation is the main mechanism in the autophagic mode of action of Sqa downstram to Atg1.
2. In the experiments in which the phospho MRLC was quantified on western blots it is important to normalize the data against total MRLC rather than Tubulin (e.g., in Figs. 4A and 4B) . Otherwise it is difficult to distinguish between effects on steady state levels of MRLC and selective phosphorylations.
3. Unlike the experiments done in the Drosophila system those done in the mammalian MCF7 cells (e.g., in Fig 6B) are less convincing. The ML-7 drug, in particular at the micromolar concentrations used in Fig. 6B looses specificity in a sense that in addition to the MLCK like kinases it may also inhibit PKA and PKC. Obviously what is missing in these experiments is the identification of the mammalian kinase which fulfills the function of Sqa described in the Drosophila system. Did the authors try to knock down DAPK3 for assessing possible effects on autophagy and MRLC phosphorylation in response to nutrient deprivation? -these experiments are easy to be done and both positive or negative results should be informative. Also why using Blebbistatin, again a drug with potential side effects instead of the non phosphorylatible mutant of human MRLC. This should be done.
Referee #2 (Remarks to the Author):
This manuscript by Tang et al. reports that myosin II activation via Atg1-mediated phosphorylation of the myosin light chain kinase-like kinase Sqa plays a key role in starvation-induced autophagy in Drosophila and cultured mammalian cells. The findings are novel and interesting, the manuscript is well written, and the data are well presented.
Specific points:
1. The authors provide convincing data that the myosin II axis regulates starvation induced autophagy. For the sake of completeness they should also examine whether this machinery also regulates developmentally induced autophagy. They have the tools for doing this, since this autphagy can be readily observed in the fat bodies of late-stage L3 Drosophila larvae using the GFPAtg8a reporter.
2. Since this study involves a number of molecular components, a figure that illustrates the key findings and the proposed model would be very helpful.
Referee #3 (Remarks to the Author):
In this manuscript Tang et al. investigated the role of the motor protein myosin II in autophagy utilizing Drosophila and mammalian systems. The authors found that Atg1 promotes a phosphorylation-dependent activation of a novel myosin light chain kinase-like protein, Sqa, which in turn phosphorylates myosin II. The authors suggest that these processes are specifically activated under starvation conditions and are required for autophagosomes formation. Myosin II was proposed here to play a role in trafficking of mAtg9 from the TGN to autophagosomes, thereby regulating the formation of autophagosomes.
The role of actin in the translocation of Atg9 upon starvation was previously described in yeast. In the present study the authors implicated myosin II in this process and characterized its regulation by Atg1 and its downstream target, Sqa. The present study is interesting and the data providing here are generally convincing. However, the physiological connection between the proposed signaling pathway and autophagy should be further characterized. Moreover, the main conclusion concerning the involvement of the new signaling pathway in autophagosomes formation is somewhat misleading. The authors should modify their conclusion to the involvement of Sqh in autophagy induction rather then autophagosomes formation.
Major comments: 1. Figure 5 -the translocation of phospho-myosin under starvation is not convincing: (i) in 5B the protein seems to be localized in the nucleus and not so much in the peri-nuclear area. (ii) in 5D it is not clear why there is a strong signal of phospho-MRLC in the absence of Atg1. (iii) Unlike the authors' claim, Sqa knockdown shown in E, and expression of the Sqh mutant presented do not convincingly affect Sqh translocation. Moreover, the authors should provide co-staining with MRLC antibodies (not specific for phosphorylation) and quantitative co-localization analysis of the data presented.
In addition, the authors should provide biochemical analysis, such as subcellular fractionation, to demonstrate this translocation. 2. Figure 6 -(i) To determine autophagic flux, the effect of lysosomal inhibitors should be tested in the experiments described in B and C. In addition, other autophagic markers (such as Atg5) should be tested.
(ii) The effect of myosin II (NHMC2A) knockdown on autophagy should be determined. (iii) What is the mammalian ortholog of Sqa? In the absence of this information it is difficult to know whether the entire pathway described in Drosophila is indeed found in mammals. 3. Figure 7 -(i) Atg9 phenotype described in A and C is not convincing. The authors should re-assure that Atg9 translocates under starvation in their experimental system. This can be achieved by co-staining with other markers and by biochemical analysis.
(ii) 7B and 7C: in addition to the treatments with drugs, the authors should knockdown NHMC2A and if possible, Sqa mammalian ortholog.
Minor comments: 1.
Figures 3D and 4A -the total level of MRLC using anti-MRLC antibodies should be presented to evaluate phosphorylation level. 2. Figure 4 . The kinetics of MRLC phosphorylation should be determined and compared to the kinetics of autophagy induction. 3. Figure 4A -the authors should provide explanation for the increased phosphorylation of MRLC in the Atg1 heterozygous cells. 4. Figure 4C -Autophagic flux should be determined using lysosomal inhibitors and provide quantification of the autophagic flux by western blot analysis.
1st Revision -authors' response 23 October 2010
We appreciate the thoughtful and constructive comments from all three reviewers. Below is our detailed response to each of the comments made by the reviewers.
Referee #1
(
1) The ultimate proof that Sqa is the relevant kinase that couples activation of Atg1 to autophagosome formation through myosin light chain phosphorylation, in response to nutrient deprivation, is still missing. It is shown that Sqa-RNAi and Sqh non phosphorylatible mutant can each inhibit autophagy; yet epistatic analysis showing that in the physiological context of amino acid starvation they function along the same pathway is missing. It is important to show in a coherent way that MRLC phosphorylation is the main mechanism in the autophagic mode of action of Sqa downstram to Atg1.
We thank the referee for this comment and we have performed epistatic assays to determine the relationship between Sqa and Sqh under starvation conditions. We found that the autophagic defects caused by Sqa-T279A mutation or Sqa-RNAi can be restored by co-expressing the constitutively active (phosphomimetic) form of Sqh (Sqh-EE and Sqh-DD) ( Figure 4I and 4J). Moreover, our in vitro and in vivo data have indicated that Thr-279 of Sqa is the major phosphorylation site of Atg1 and is required for the activation of Sqa (Figure 3 , S4, and S5). These results together with our biochemical and genetic data ( Figure 1H , 2J, and 4B) not only indicate that Sqh is the primary phosphorylation target of Sqa in starvation-induced autophagy, but also suggest that Sqh phosphorylation is a major mechanism in the autophagic mode of action of Sqa downstram to Atg1.
(2) The reviewer notes that "In the experiments in which the phospho MRLC was quantified on western blots it is important to normalize the data against total MRLC rather than Tubulin (e.g., in Figs. 4A and 4B) . Otherwise it is difficult to distinguish between effects on steady state levels of MRLC and selective phosphorylations."
We have presented new data in which the fold changes of phospho MRLC was quantified and normalized to total MRLC ( Figure 3D , 4A, 4B, and S1A). In response to this recommendation, we performed studies using lentival shRNA-mediated knockdown of Ulk1, ZIPK (DAPK3), and NMHC2A in MCF7 cells. Consistent with the data from cells treated with ML-7 and Blebbistatin (Supplementary Figure S7A and S7B), depletion of ZIPK and NMHC2A strongly impaired starvation-induced autophagy ( Figure 6 ). In addition, we presented new data demonstrating that mammalian Atg1 (Ulk1) interacts with and phosphorylates ZIPK (in revised Figure 5A and 5B). We found that both Ulk1 and ZIPK are required for MRLC phosphorylation in response to nutrient deprivation ( Figure 5D ). These results along with the high sequence homolog between ZIPK and Sqa suggest that ZIPK is the mammalian homolog of Sqa.
Referee #2
( We thank the referee for this comment. Unfortunately, because lipid droplets in the fat bodies of late third instar Drosophila larvae caused a strong background, we technically could not perform the above experiment. We agree that an understanding the role of Sqa-Sqh signaling in developmentally induced autophagy is very important, but it will clearly require more extensive studies to elucidate the mechanism, and so many studies might obscure the main focus of our manuscript.
(2) The reviewer suggests us to include a figure that illustrates the key findings and the proposed model.
As the reviewer suggests, we have included a model that illustrates our key findings in Supplementary Figure S10 .
Referee #3 
the main conclusion concerning the involvement of the new signaling pathway in autophagosomes formation is somewhat misleading. The authors should modify their conclusion to the involvement of Sqh in autophagy induction rather then autophagosomes formation.
We thank the referee for his/her positive and constructive comments. We have performed several additional studies to further characterize the physiological connection between Sqa-Sqh signaling and starvation-induced autophagy both in Drosophila and mammalian cells. The reviewer also raised concerns about our conclusion on the involvement of myosin II in autophagosome formation as opposed to its involvement in autophagy induction. The formation of autophagosomes occurs through a process that involves initiation and the nucleation of isolation membranes, elongation and expansion of autophagosomal membrane, and the closure and maturation of autophagosomes. Although we cannot rule out the possibility that Sqa-Sqh signaling may play a role in the induction of autophagy, several lines of evidence suggest that Sqh is involved in the early steps of autophagosome formation. First, unlike Atg13 and Atg17, which form complex with Atg1 in mediating the induction of autophagy, our biochemical and genetic data indicated that Sqa-Sqh functions downstream of Atg1 (Figure 1 and 2) . Second, we found that depletion of Sqa and Sqh mutant resulted in a significant decrease in number and size of autophagosomes under starvation conditions (Figure 4 ). When mammalian cells were deprived of nutrients, myosin II inhibition and ZIPK depletion also resulted in a marked decrease in number and size of autophagosomes, as indicated by GFP-LC3 and Atg16 (Figure 6 and S7). It has been shown that Atg16 is localized on isolation membranes and is essential for the elongation of isolation membranes (Mizuchima et al., J Cell Sci., 2003 . 116:1679 , thus suggesting that myosin II plays a role in early autophagosome formation. Third, our data showed that myosin II colocalized and interacted with Atg9 in response to nutrient deprivation (Figure 8 ). Finally, we found that Ulk1-ZIPK-mediated myosin II activation is required for myosin-Atg9 interaction and Atg9 trafficking (Figure 8 ). The transmembrane protein Atg9 has been proposed to promote lipid transport to the forming autophagosomes, and thus regulates phagophore expansion during the formation of autophagosomes (Mari & Reggiori, 2007. Autophagy 3:145-148; Webber et al, 2007. Autophagy 3: 54-56) . Taken together, these results suggest that Atg1-mediated myosin II activation plays a critical role in the early stages of autophagosome formation. We have modified our conclusion to make the involvement of Sqa-Sqh signaling in the Atg9-mediated autophagosome formation more apparent.
Major points:
(1) Figure 5- We thank the reviewer for this comment. We have presented a new figure which showed a perinuclear distribution of Sqh-GFP and phospho-MRLC under starvation conditions ( Figure 7A ). We agree that the involvement of Atg1-Sqa signaling on the translocation of Sqh should be examined with both anti-phospho-MRLC and anti-MRLC antibodies. Unfortunately, for technical reasons, we were not able to reliably detect MRLC signals in the larval fat body cells with the antiSqh antibody we obtained. Thus, we removed the data regarding the involvement of Atg1-Sqa signaling on Sqh translocation in the revised manuscript. We have combined our results on the starvation-induced translocation of Drosophila and mammalian myosin-II in the new Figure 7A and 7B. In addition, we have encountered technical difficulties in performing subcellular fractionation experiments using larval fat body cells. We thus performed the subcellular fractionation study in mammalian cells ( Figure 7C ). Our data show that nutrient starvation induces myosin II redistribution and that this process is conserved from Drosophila to mammalian cells.
(2) Figure 6 -(i) To determine autophagic flux, the effect of lysosomal inhibitors should be tested in the experiments described in B and C. In addition, other autophagic markers (such as Atg5) should be tested.
In response, we have determined the autophagic flux by monitoring the turnover of LC3 in the presence or absence of bafilomycin A1 (lysosomal inhibitor). We have included the data in the revised figure 6 and S7. Besides GFP-LC3, we have used Atg16 as an autophagic marker. Our results showed that compared with controls, depletion of ZIPK or NMHC2A resulted in a significant decrease in the number of Atg16-labelled puncta formation under starvation conditions ( Figure S7 ).
(ii) The effect of myosin II (NHMC2A) knockdown on autophagy should be determined.
As indicated above in response to reviewer 1's concerns, we have presented new data ( Figure 6 ) in the revised manuscript.
(iii) What is the mammalian ortholog of Sqa? In the absence of this information it is difficult to know whether the entire pathway described in Drosophila is indeed found in mammals.
As indicated above in response to reviewer 1's comments, we have included several new experimental results which indicate that ZIPK (DAPK3) is the mammalian homolog of Sqa in the revised manuscript.
(3) Figure 7 -(i) Atg9 phenotype described in A and C is not convincing. The authors should reassure that Atg9 translocates under starvation in their experimental system. This can be achieved by co-staining with other markers and by biochemical analysis.
As suggested by the reviewer, we have included new data demonstrating the translocation of Atg9 under starvation by co-staining with markers including TGN46, GM130, LAMP1, Rab7, and LC3 (Figure 8 and S8).
As indicated above in response to reviewer 1's concerns, we have knocked down the expression of NMHC2A and the Sqa mammalian homolog ZIPK. We have presented new data (Figure 8 ) in the revised manuscript.
Minor points:
1. Figures 3D and 4A -the total level of MRLC using anti-MRLC antibodies should be presented to evaluate phosphorylation level.
We have presented new data in which the fold changes of phospho-MRLC was quantified and normalized to total MRLC ( Figure 3D , 4A, 4B, and S1A).
Figure 4. The kinetics of MRLC phosphorylation should be determined and compared to the kinetics of autophagy induction.
We have performed the study in mammalian cells and have included the new data in the revised Supplementary Figure S6 .
3. Figure 4A -the authors should provide explanation for the increased phosphorylation of MRLC in the Atg1 heterozygous cells.
The increased phospho-MRLC in the Atg1 heterozygous cells was likely due to a longer exposure of the immunoblot. We have presented new data in the revised manuscript. Figure 4C -Autophagic flux should be determined using lysosomal inhibitors and provide quantification of the autophagic flux by western blot analysis.
4.
We thank the reviewer for this comment. However, the study in Figure 4C was performed using the Flip-out GAL4 system to clonally express Sqa and Sqh mutants in the Drosophila larval fat body cells. There were only a few mutant clones, and it was technically difficult to separate them from the control cells for the western blot analysis.
2nd Editorial Decision 16 November 2010
Many thanks for submitting the revised version of your manuscript EMBOJ-2010-74860R. It has now been seen again by all three referees, whose comments are enclosed below. As you will see, referees 2 and 3 now find the manuscript to be suitable for publication without further revision, but referee 1 -while overall supportive of publication -has some concerns regarding the new data presented in figure 5 . He/she finds that the evidence for direct phosphorylation of DAPK3/ZIPK by ULK1 to be somewhat unconvincing. Given his/her comments, I would strongly encourage you to do the following in a final revision of your manuscript: -Repeat the experiment shown in Figure 5A with equivalent loading of DAPK3, such that the results can be more directly compared.
-Replace Figure 5D with a more representative blot, or minimally tone down your conclusions from this panel.
-Rephrase the text throughout to ensure that it is clear that you have not directly shown that ULK1 phsophorylates ZIPK, nor that this regulation is critical for autophagy.
I would also ask you to include an author contributions statement below your acknowledgementswe are currently implementing this as a policy requirement at the journal.
I hope that these final changes should not be too time-consuming, and please do let me know if you have any questions or comments. Once we have this next version, we should then be able to accept the manuscript for publication in EMBOJ.
Best wishes, REFEREE REVIEWS Referee #1 (Remarks to the Author):
The responses to the first two comments are OK and add to the quality of the paper. Yet there is still some concern about the new results which suggest that DAPK3 (ZIPK) is the mammlian orthologue of Sqa fulfilling a similar regulation/ function in autophagy (comment 3). In Fig 5A , the authors conclude that wt ULK1 like Atg1 does not bring down DAPK3, in contrast to the kinase dead Ulk1-but there is much more DAPK3 expressed with the latter and therefore this statement is not conclusive. It is not convincing from Fig.5B that ULK1 phosphorylates directly DAPK3 like in the case of Atg1/Sqa interactions. The migration shift is not typical to DAPK3 phosphorylation on the site corresponding to 279 in Sqa, the migration shift could be indirect, and unfortunately this is the only documentation brought in the paper for suggesting a direct phosphorylation of DAPK3 by ULK1 (as suggested in the final model). The blot in Fig.5D -right panel, suggesting that the knock down of DAPK3 reduces MRLC phosphorylation is not convincing (although we agree that the scanning show significant effects). The effect of DAPK3 depletion on autophagy is convincing yet it could work through other pathways-there is no proof with a dominant negative mutant resistant to ULK-1 phosphorylation which was not mapped. Overall, the issue of MRLC phosphorylation through DAPK3 after its activation by ULK1 in starved MCF7 cells is not as convincing as in the Drosophila system. So the reviewer suggests to be more cautious in their statement that DAPK3 is the mammalian orthologue of Sqa, sharing the same pathways, along the abstract, discussion as well as in the model.
The authors have successfully addressed the points I raised. In my opinion, this revised manuscript is acceptable for publication.
The authors addressed all my comments and added substantial amount of new data to solidify their model. Overall this is an excellent piece of work that fully deserves to be published in EMBO Journal. We thank referee #1 very much for the thoughtful comments. We have presented a new Figure 5A with equivalent loading of ZIPK (DAPK3) and have modified our conclusion from Figure 5D (page 14 of the revised manuscript). We agree that we have not directly shown that Ulk1 phosphorylates ZIPK, nor the involvement of this regulation in autophagy. However, several lines of evidence suggest that ZIPK may act as the mammalian homolog of Sqa during starvation induced autophagy. First, our sequence analysis revealed that both Sqa and ZIPK contain an amino-terminal kinase domain that has 42% sequence identity and 61% similarity. Second, as phosphorylation of Thr-265 in ZIPK is essential for its kinase activity (Sato et al., Immunol Lett 2006. 103: 127-134) , we found that Atg1 phosphorylates Sqa at the corresponding Thr-279, and is critical for Sqa activity. Third, just as Sqa specifically associates with kinase inactive Atg1, our results indicate a similar interaction between ZIPK and Ulk1. Finally, we found that depletion of Sqa and ZIPK resulted in autophagic defects in response to nutrient deprivation. We have rephrased the text in the abstract and the Discussion section (page 19 of the revised manuscript) and have modified our model in Figure S10 in accordance to reviewer's comments.
Accepted 24 November 2010
Many thanks for submitting the revised version of your manuscript -I have now had the chance to look through it, and everything looks fine. I am therefore pleased to be able to tell you that we can accept the manuscript for publication in the EMBO Journal without further delay -you should receive the formal acceptance email shortly.
Many thanks for choosing EMBOJ for publication of this study, and congratulations on a fine piece of work!
